Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; MediCity Research Laboratory, University of Turku, Turku, Finland
Daichi Kobayashi
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
Keita Aoi
WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Department of Immunology and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan
Naoko Sasaki
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan
Yuki Sugiura
Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan; JST Precursory Research for Embryonic Science and Technology project, Saitama, Japan
Hidemitsu Igarashi
Department of Immunology, Graduate School of Medicine, Akita University, Akita, Japan
Kazuo Tohya
Department of Anatomy, Kansai University of Health Sciences, Awaji, Japan
Asuka Inoue
Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
Erina Hata
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
Noriyuki Akahoshi
Department of Immunology, Graduate School of Medicine, Akita University, Akita, Japan
Haruko Hayasaka
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
Junichi Kikuta
WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Department of Immunology and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan
Elke Scandella
Institute of Immunobiology, Kantonal Hospital St. Gallen, St. Gallen, Switzerland
Burkhard Ludewig
Institute of Immunobiology, Kantonal Hospital St. Gallen, St. Gallen, Switzerland
Satoshi Ishii
Department of Immunology, Graduate School of Medicine, Akita University, Akita, Japan
Junken Aoki
Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
Makoto Suematsu
Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan; Core Research for Evolutional Science and Technology project, Saitama, Japan
Masaru Ishii
WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Department of Immunology and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan
Kiyoshi Takeda
WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Laboratory of Immune Regulation, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan
Sirpa Jalkanen
MediCity Research Laboratory, University of Turku, Turku, Finland
Masayuki Miyasaka
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; MediCity Research Laboratory, University of Turku, Turku, Finland
Eiji Umemoto
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
Lymph nodes (LNs) are highly confined environments with a cell-dense three-dimensional meshwork, in which lymphocyte migration is regulated by intracellular contractile proteins. However, the molecular cues directing intranodal cell migration remain poorly characterized. Here we demonstrate that lysophosphatidic acid (LPA) produced by LN fibroblastic reticular cells (FRCs) acts locally to LPA2 to induce T-cell motility. In vivo, either specific ablation of LPA-producing ectoenzyme autotaxin in FRCs or LPA2 deficiency in T cells markedly decreased intranodal T cell motility, and FRC-derived LPA critically affected the LPA2-dependent T-cell motility. In vitro, LPA activated the small GTPase RhoA in T cells and limited T-cell adhesion to the underlying substrate via LPA2. The LPA-LPA2 axis also enhanced T-cell migration through narrow pores in a three-dimensional environment, in a ROCK-myosin II-dependent manner. These results strongly suggest that FRC-derived LPA serves as a cell-extrinsic factor that optimizes T-cell movement through the densely packed LN reticular network.